BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16012720)

  • 1. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
    Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
    Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.
    Terakawa N; Kanamori Y; Yoshida S
    Endocr Relat Cancer; 2003 Jun; 10(2):203-8. PubMed ID: 12790783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
    Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.
    Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X
    Int J Gynecol Pathol; 2005 Jul; 24(3):247-53. PubMed ID: 15968200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.
    Kanamori Y; Kigawa J; Itamochi H; Sultana H; Suzuki M; Ohwada M; Kamura T; Sugiyama T; Kikuchi Y; Kita T; Fujiwara K; Terakawa N
    Int J Cancer; 2002 Aug; 100(6):686-9. PubMed ID: 12209607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations of p-AKT with PTEN, P53, HER-2 expressions in endometrial carcinoma and their relationship with patient survival].
    Zhang XM; Liang Y; Dong Y; Zhang Y; Wang Y; Meng YT; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):135-41. PubMed ID: 22353917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group.
    Ma BB; Oza A; Eisenhauer E; Stanimir G; Carey M; Chapman W; Latta E; Sidhu K; Powers J; Walsh W; Fyles A
    Int J Gynecol Cancer; 2004; 14(4):650-8. PubMed ID: 15304161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
    Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome.
    Peiró G; Lohse P; Mayr D; Diebold J
    Am J Clin Pathol; 2003 Jul; 120(1):78-85. PubMed ID: 12866376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
    Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
    Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
    Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
    Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
    Lilja JF; Wu D; Reynolds RK; Lin J
    Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.
    Tang JM; He QY; Guo RX; Chang XJ
    Lung Cancer; 2006 Feb; 51(2):181-91. PubMed ID: 16324768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
    Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
    Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
    Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
    Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
    Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
    Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.